Other therapy.
Survival Outcomes for Patients With Invasive Lobular Cancer by MammaPrint: Results From the MINDACT Phase III Trial
Publication: European Journal of Cancer 217 (2025) 115222 Authors: Read More
Other therapy.
Publication: European Journal of Cancer 217 (2025) 115222 Authors: Read More
Source: San Antonio Breast Cancer Symposiumยฎ Authors: Robert Maganini, Read More
Publication: ESMO Open - Volume 9 - Issue 11 Read More
Publication: ESMO 2024 Authors: Sonya Reid, M.D., Jennifer G. Read More
Cureus, part of Springer Nature Author: Jiang et al.
Read MoreThe Breast 76 (2024) 103752 Author: Mansani et al.
Read More: Cost consequence model of the MammaPrintยฎ (70-gene signature) and 21-gene signature in Patients with primary HR+ HER2-, N1 early-stage breast cancer in Germany
Read MoreSSO 2024 Author: Solis-Pomales et al.
Read MoreJournal of Clinical Oncology, April 9, 2024 Presenter: Rios-Hoyo et al.
Read More2024 European Breast Cancer Conference (EBCC) (Abstract 2LBA) Presenter: Wolf et al.
Read More